Berger Mark Stanley
Insider transactions at 2 companies
This page shows all SEC Form 4 filings attributed to Berger Mark Stanley. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| GNPX | Chief Medical Officer | Award / Grant | 28,500 | — | — | Dec 22, 2025 |
| GNPX | Chief Medical Officer | Tax Withholding | 4,500 | $0.23 | $1,035 | Jun 30, 2025 |
| GNPX | Chief Medical Officer | Tax Withholding | 585 | $0.41 | $240 | Feb 18, 2025 |
| GNPX | Chief Medical Officer | Award / Grant | 18,250 | — | — | Dec 5, 2024 |
| GNPX | Chief Medical Officer | Tax Withholding | 1,319 | $4.40 | $5,804 | Feb 18, 2024 |
| GNPX | Chief Medical Officer | Award / Grant | 245,000 | — | — | Feb 18, 2023 |
| ATNM | Chief Medical Officer | X | 3,500 | $0.60 | $2,100 | Mar 5, 2019 |
| ATNM | Chief Medical Officer | Other | 14,000 | $0.50 | $7,000 | Mar 6, 2018 |
| ATNM | Chief Medical Officer | Purchase | 5,000 | $1.11 | $5,550 | Jun 15, 2017 |